Cargando…
Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s disease
Alpha-synuclein (aS) amyloid formation is involved in Parkinson’s disease (PD); therefore, small molecules that target aS and affect its aggregation are of interest as future drug candidates. We recently reported modified ring-fused 2-pyridones that modulate aS amyloid formation in vitro. Here, we d...
Autores principales: | Pokrzywa, Małgorzata, Pawełek, Katarzyna, Kucia, Weronika Elżbieta, Sarbak, Szymon, Chorell, Erik, Almqvist, Fredrik, Wittung-Stafshede, Pernilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581160/ https://www.ncbi.nlm.nih.gov/pubmed/28863169 http://dx.doi.org/10.1371/journal.pone.0184117 |
Ejemplares similares
-
Single injection of small-molecule amyloid accelerator results in cell death of nigral dopamine neurons in mice
por: Chermenina, Maria, et al.
Publicado: (2015) -
Crossroads between copper ions and amyloid formation in Parkinson’s disease
por: Wittung-Stafshede, Pernilla
Publicado: (2022) -
Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts
por: Chorell, Erik, et al.
Publicado: (2015) -
Chemical catalysis by biological amyloids
por: Wittung-Stafshede, Pernilla
Publicado: (2023) -
Mechanisms of Protein
Oligomerization: Inhibitor of
Functional Amyloids Templates α-Synuclein Fibrillation
por: Horvath, Istvan, et al.
Publicado: (2012)